Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Pharma
How biosimilar developers are embracing next phase of US market
Although the so-called biosimilar ‘void’ could pose challenges to upcoming biosimilar availability, the opportunity it presents is also immense.
Zoey Becker
,
Fraiser Kansteiner
Jul 6, 2026 10:03am
Colorado wins FDA approval to import cheaper drugs from Canada
Jun 17, 2026 10:30am
PhRMA talks up the power of ‘Medicines First’ in new campaign
Jun 16, 2026 8:09am
Germany scraps variable discount plan meant to cut costs: report
Jun 15, 2026 3:30pm
Fierce Healthcare
CMS proposal would lock in Medicare drug price negotiations
Jun 12, 2026 5:50pm
5 EU countries call for 'unity' in Europe's drug pricing approach
Jun 11, 2026 11:27am